Preclinical antibiotic pipeline gets a pick-me-up
Nature Reviews Drug Discovery 16, 741 (2017).
doi:10.1038/nrd.2017.213
Author: Asher Mullard
CARB-X, a public–private partnership aimed at bolstering the antibiotic pipeline, funded a diverse set of 17 early-stage drug development projects in its first year.
Source: Nature Reviews Drug Discovery - Category: Drugs & Pharmacology Authors: Asher Mullard Tags: News and Analysis Source Type: research
More News: Drugs & Pharmacology | Partnerships